PCI versus CABG in patients with complex coronary artery disease: Time for reconciliation?

Authors

  • Ahmed M ElGuindy Department of Cardiology, Aswan Heart Centre, Aswan, Egypt
  • Ahmed Afifi Department of Cardiac Surgery, Aswan Heart Centre, Aswan, Egypt

Abstract

Final 5-year results of the Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial were recently presented at the Transcatheter Cardiovascular Therapeutics (TCT) and European Society of Thoracic Surgery (ESTS) meetings. SYNTAX is frequently quoted as “the most important percutaneous coronary intervention (PCI) vs. coronary artery bypass grafting (CABG) trial in multivessel and/or left main (LM) coronary artery disease (CAD) conducted to date”. However, the impact of its findings on day-to-day clinical practice remains surprisingly humble. 

Downloads

Published

2017-01-09

Issue

Vol. 2012 No. 2 (2012)

Section

Lessons from the trials

License

This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.